Dr. Iraj Beheshti, Ph.D., M.B.A., Vice President and Director of Clinical Reference Laboratories. Dr. Beheshti was Co-Founder and Director of Research and Development (1985-1988) and President and CEO of London Diagnostics (1988-1993). Prior to that he was Senior Scientist with Abbott Laboratories. Before joining NYMOX, Dr. Beheshti was Director of Operations of Acute Care and Outpatient Laboratories at the University of Minnesota Medical School. Dr. Beheshti is an authority in the medical diagnostics field and in affairs dealing with the U.S. Food and Drug Administration. He has been involved in the successful development and commercialization of numerous products, including 14 FDA approved diagnostic kits.
Dr. Iraj Beheshti served as General Manager of Elitra Pharmaceutical’s Fungal Research Center in Montreal, Canada. Prior to joining Elitra, Dr. Beheshti served as President and CEO of Mycota Biosciences, before Elitra acquired it in 2001. He has also held various research and management positions at Abbott Laboratories, Nymox Pharmaceutical, the clinical laboratories at the University of Minnesota Hospital and Clinic, and London Diagnostics. He is a co-inventor on several issued patents relating to inventions he made as a founder and president of London Diagnostics. He has a Ph.D. in Organic Chemistry from the University of Sussex, Britain.